Perkins Capital Management’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $511K | Buy |
227,000
+21,500
| +10% | +$48.4K | 0.51% | 48 |
|
|
2025
Q1 | $282K | Sell |
205,500
-2,000
| -1% | -$2.74K | 0.3% | 67 |
|
|
2024
Q4 | $328K | Sell |
207,500
-10,000
| -5% | -$15.8K | 0.29% | 65 |
|
|
2024
Q3 | $270K | Sell |
217,500
-17,000
| -7% | -$21.1K | 0.25% | 69 |
|
|
2024
Q2 | $314K | Buy |
234,500
+6,000
| +3% | +$8.03K | 0.3% | 66 |
|
|
2024
Q1 | $311K | Buy |
228,500
+15,000
| +7% | +$20.4K | 0.26% | 71 |
|
|
2023
Q4 | $559K | Buy |
213,500
+1,700
| +0.8% | +$4.45K | 0.48% | 60 |
|
|
2023
Q3 | $678K | Sell |
211,800
-4,200
| -2% | -$13.4K | 0.67% | 45 |
|
|
2023
Q2 | $1.09M | Sell |
216,000
-8,800
| -4% | -$44.2K | 0.95% | 37 |
|
|
2023
Q1 | $647K | Buy |
224,800
+189,000
| +528% | +$544K | 0.61% | 50 |
|
|
2022
Q4 | $84K | Buy |
35,800
+14,800
| +70% | +$34.7K | 0.09% | 85 |
|
|
2022
Q3 | $94K | Sell |
21,000
-600
| -3% | -$2.69K | 0.11% | 88 |
|
|
2022
Q2 | $127K | Buy |
21,600
+11,300
| +110% | +$66.4K | 0.13% | 88 |
|
|
2022
Q1 | $67K | Buy |
+10,300
| New | +$67K | 0.05% | 104 |
|
|
2020
Q1 | $151K | Sell |
42,200
-300
| -0.7% | -$1.07K | 0.18% | 77 |
|
|
2019
Q4 | $360K | Sell |
42,500
-157,040
| -79% | -$1.33M | 0.32% | 74 |
|
|
2019
Q3 | $1.35M | Sell |
199,540
-54,500
| -21% | -$369K | 1.16% | 32 |
|
|
2019
Q2 | $1.71M | Buy |
254,040
+8,500
| +3% | +$57.1K | 1.2% | 28 |
|
|
2019
Q1 | $1.55M | Sell |
245,540
-220,160
| -47% | -$1.39M | 1.02% | 29 |
|
|
2018
Q4 | $3.02M | Buy |
465,700
+350
| +0.1% | +$2.27K | 2.34% | 6 |
|
|
2018
Q3 | $3.3M | Buy |
465,350
+64,650
| +16% | +$459K | 1.98% | 8 |
|
|
2018
Q2 | $1.74M | Buy |
400,700
+146,450
| +58% | +$637K | 1.25% | 22 |
|
|
2018
Q1 | $755K | Sell |
254,250
-212,050
| -45% | -$630K | 0.68% | 50 |
|
|
2017
Q4 | $1.21M | Sell |
466,300
-157,385
| -25% | -$409K | 1.17% | 27 |
|
|
2017
Q3 | $2.11M | Buy |
623,685
+23,868
| +4% | +$80.7K | 2.21% | 9 |
|
|
2017
Q2 | $1.48M | Sell |
599,817
-30,501
| -5% | -$75.4K | 1.64% | 16 |
|
|
2017
Q1 | $1.68M | Sell |
630,318
-1,717
| -0.3% | -$4.59K | 1.74% | 14 |
|
|
2016
Q4 | $2.27M | Sell |
632,035
-15,000
| -2% | -$53.9K | 2.49% | 8 |
|
|
2016
Q3 | $3.37M | Buy |
647,035
+291,295
| +82% | +$1.52M | 3.37% | 4 |
|
|
2016
Q2 | $583K | Sell |
355,740
-20,969
| -6% | -$34.4K | 0.67% | 52 |
|
|
2016
Q1 | $629K | Buy |
376,709
+2,000
| +0.5% | +$3.34K | 0.79% | 45 |
|
|
2015
Q4 | $787K | Buy |
374,709
+80,750
| +27% | +$170K | 0.84% | 39 |
|
|
2015
Q3 | $573K | Hold |
293,959
| – | – | 0.64% | 54 |
|
|
2015
Q2 | $820K | Buy |
293,959
+43,959
| +18% | +$123K | 0.72% | 46 |
|
|
2015
Q1 | $598K | Buy |
+250,000
| New | +$598K | 0.5% | 71 |
|